ARYMO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Arymo, and when can generic versions of Arymo launch?
Arymo is a drug marketed by Zyla and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in ARYMO is morphine sulfate. There are twenty-three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Arymo
A generic version of ARYMO was approved as morphine sulfate by HOSPIRA on September 30th, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ARYMO?
- What are the global sales for ARYMO?
- What is Average Wholesale Price for ARYMO?
Summary for ARYMO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for ARYMO |
| DailyMed Link: | ARYMO at DailyMed |
US Patents and Regulatory Information for ARYMO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-001 | Jan 9, 2017 | DISCN | Yes | No | 9,549,899 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-002 | Jan 9, 2017 | DISCN | Yes | No | 9,549,899 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-001 | Jan 9, 2017 | DISCN | Yes | No | 9,044,402 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-002 | Jan 9, 2017 | DISCN | Yes | No | 9,044,402 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-003 | Jan 9, 2017 | DISCN | Yes | No | 9,044,402 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-003 | Jan 9, 2017 | DISCN | Yes | No | 9,549,899 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
